<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01714401</url>
  </required_header>
  <id_info>
    <org_study_id>TJ-1</org_study_id>
    <nct_id>NCT01714401</nct_id>
  </id_info>
  <brief_title>Nebulized Bronchodilatators and Cardiac Repolarization</brief_title>
  <official_title>The Development of Procedures to Optimalize the Intensive Care Units Patients Clinical Condition. Evaluation of Influence of Nebulized Bronchodilatatory Drugs on Cardiac Repolarization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Gdansk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Gdansk</source>
  <brief_summary>
    <textblock>
      Patients of the ICU's often require bronchodialtatory treatment due to bronchospazm caused by
      conditions like : ARDS, COPD or asthma. The β2 adreneregic drugs are one of the most commonly
      used for this purpose. However it is known that they may cause tachycardia and may have
      substantial proarrhythmic effect. The investigators' aim is to estimate the influence of
      nebulized bronchodilatatory drugs on selected electrophysiological parameters, whose changes
      are generally recognized as potentially increasing the risk of ventricular and
      supraventricular arrhythmias. Two drugs will be compared - salbutamol given in two doses and
      ipratropium bromide
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of electrophysiological parameters after nebulized bronchodilatator</measure>
    <time_frame>one hour</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Influence of Nebulized Bronchodilatators on Selected</condition>
  <condition>Electrophysiological Parameters</condition>
  <arm_group>
    <arm_group_label>Salbutamol 2,5 mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Salbutamol 5mg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ipratropium 0.5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ventolin 2.5mg</intervention_name>
    <description>20 min nebulization of 2.5 mg of salbutamol</description>
    <arm_group_label>Salbutamol 2,5 mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ventolin 5mg</intervention_name>
    <description>20 min nebulization of 5 mg of salbutamol</description>
    <arm_group_label>Salbutamol 5mg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Atrovent 0.5mg</intervention_name>
    <description>20 min nebulization of 0.5 mg of ipratropium bromide</description>
    <arm_group_label>Ipratropium 0.5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the necessity of b2 adrenergics an m2 mimetics administration

        Exclusion Criteria:

          -  patients with past medical history of ventricular arrhythmias ( ventricular
             tachycardia, ventricular fibril, Torsade de pointes)

          -  patients with persistent atrial fibrillation

          -  patients with abnormal plasma sodium, potassium, magnesium, and ionized calcium
             concentration
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tomasz Jasinski, MD</last_name>
    <phone>0048-058-349-32-82</phone>
    <email>tjasinski@uck.gda.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Gdansk - Departament of Anesthesiolog and Intensive cCre</name>
      <address>
        <city>Gdansk</city>
        <zip>80-214</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Jasinski, MD</last_name>
      <email>tjasinski@uck.gda.pl</email>
    </contact>
    <investigator>
      <last_name>Radoslaw Owczuk, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Jasinski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Gdańsk - Departament of Anesthesiology and Intensive Care</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-214</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Radoslaw Owczuk, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Jasinski, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2012</study_first_submitted>
  <study_first_submitted_qc>October 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2012</study_first_posted>
  <last_update_submitted>October 24, 2012</last_update_submitted>
  <last_update_submitted_qc>October 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Gdansk</investigator_affiliation>
    <investigator_full_name>Radoslaw Owczuk</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Albuterol</mesh_term>
    <mesh_term>Ipratropium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

